Pittsburgh Glomerulonephritis Symposium

May 4, 2024

Glomerulonephritis (GN) is a rare kidney disease that can lead to increased morbidity and End-stage kidney disease. Most nephrologists have limited exposure in dealing with complex GN patients. Recently, in last three years, there have been many new medications that have received FDA approval for managing these patients. There is still uncertainty with respect to which patients would be ideal for newer medications and how to balance risk-benefit ratio. Main goal of this symposium would be to discuss updates in management of GNs with emphasis on practical approach for patient care.

Target Audience

Physicians, Nurse practitioners, Nurses, Fellows, Residents

Learning Objectives

Participants after completion of this activity should:
- Discuss the diagnosing and treatment of patients with Membranous nephropathy
-Review  newer treatment options and change in guidelines for patients with Lupus nephritis
- Discuss how to diagnose and manage patients with ANCA vasculitis
- Review the risk factors and newer treatments for IgA nephropathy
- Review common pediatric glomerular diseases

Additional Information

PDF icon MX3429051_CME_PittGlomSymp_STD_FS.pdf339.18 KB
Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
Course expires: 
Event starts: 
05/04/2024 - 8:00am EDT
Event ends: 
05/04/2024 - 3:00pm EDT


Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credits to be determined




Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance


Please login or register to take this course.